The Latest Trading Price of Gujarat Alkalies & Chemicals Ltd is ₹ 538.15 as of 20 Mar 15:30
. The P/E Ratio of Gujarat Alkalies & Chemicals Ltd changed from 15.3 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 278.3 on March 2025 . This represents a CAGR of 51.09% over 4 years The Market Cap of Gujarat Alkalies & Chemicals Ltd changed from ₹ 2530 crore on March 2021 to ₹ 4252 crore on March 2025 . This represents a CAGR of 10.94% over 5 yearsThe Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 5115 crore on March 2022 to ₹ 1588 crore on March 2025 . This represents a CAGR of -25.35% over 4 years The revenue of Gujarat Alkalies & Chemicals Ltd for the Dec '25 is ₹ 1074 crore as compare to the Sep '25 revenue of ₹ 1142 crore. This represent the decline of -5.92% The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The ebitda of Gujarat Alkalies & Chemicals Ltd for the Dec '25 is ₹ 126.48 crore as compare to the Sep '25 ebitda of ₹ 133.25 crore. This represent the decline of -5.08% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The net profit of Gujarat Alkalies & Chemicals Ltd changed from ₹ -44.53 crore to ₹ -19.95 crore over 7 quarters. This represents a CAGR of -36.80%
The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17%
The Dividend Payout of Gujarat Alkalies & Chemicals Ltd changed from 35.21 % on March 2021 to 733.47 % on March 2025 . This represents a CAGR of 83.55% over 5 yearsThe Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 years .
About Gujarat Alkalies & Chemicals Ltd
Gujarat Alkalies and Chemicals Limited (GACL) is one of the largest producers of Caustic Soda Lye in India with present installed production capacity of 5,85,750 lakhs MT as on March 31, 2025.
Company was incorporated in March, 1973 at Gujarat and promoted by Gujarat Industrial Investment Corporation Limited, a wholly owned company of Govt. of Gujarat, as a core Promoter.
The Company's products basket comprise of more than 36 products including Caustic Soda (Lye, Flakes/Prills), Liquid Chlorine, Hydrochloric Acid, Chloromethanes, Hydrogen Peroxide, Anhydrous Aluminum Chloride, Caustic Potash (Lye & Flakes), Potassium Carbonate, Aluminium Chloride, Phosphoric Acid, Chlorinated Paraffin, Poly Aluminium Chloride (various grades), Chlorotoluene, Sodium Chlorate, etc.
The company has two units located at Vadodara (Baroda) and Dahej, both in Gujarat.
About Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani.
The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).
FAQs for the comparison of Gujarat Alkalies & Chemicals Ltd and Tatva Chintan Pharma Chem Ltd
Which company has a larger market capitalization, Gujarat Alkalies & Chemicals Ltd or Tatva Chintan Pharma Chem Ltd?
Market cap of Gujarat Alkalies & Chemicals Ltd is 3,952 Cr while Market cap of Tatva Chintan Pharma Chem Ltd is 2,637 Cr
What are the key factors driving the stock performance of Gujarat Alkalies & Chemicals Ltd and Tatva Chintan Pharma Chem Ltd?
The stock performance of Gujarat Alkalies & Chemicals Ltd and Tatva Chintan Pharma Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Gujarat Alkalies & Chemicals Ltd and Tatva Chintan Pharma Chem Ltd?
As of March 23, 2026, the Gujarat Alkalies & Chemicals Ltd stock price is INR ₹538.15. On the other hand, Tatva Chintan Pharma Chem Ltd stock price is INR ₹1127.45.
How do dividend payouts of Gujarat Alkalies & Chemicals Ltd and Tatva Chintan Pharma Chem Ltd compare?
To compare the dividend payouts of Gujarat Alkalies & Chemicals Ltd and Tatva Chintan Pharma Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.